The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2025 Jan 8

PMID 39769097

Authors

Hao Lyu

Jinghua Kong

Jiasi Chen

Rui Zhang

Shuai Xiao

Dong Guo

Qi Zhang

Xing-Zhen Chen

Jingfeng Tang

Cefan Zhou

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer remains one of the most lethal forms of cancer. Currently, there is a lack of effective drug treatments for pancreatic cancer. However, as a newly discovered form of non-apoptotic cell death, ferroptosis has garnered increasing attention in relation to pancreatic cancer. Understanding the role of ferroptosis in the tumorigenesis and treatment of pancreatic cancer may enable more effective clinical trials and treatments for pancreatic cancer and may minimize side effects or restrict the emergence of drug resistance. In this review, we summarize the current knowledge regarding the process and underlying mechanisms of ferroptosis, as well as its dual role in both promoting tumorigenesis and facilitating treatment strategies for pancreatic cancer. Additionally, how ferroptosis is implicated in the development of pancreatitis and insulin resistance, indicating that ferroptosis may play an important role in the risk of pancreatitis- and insulin-resistance-related pancreatic cancers, is also addressed.

References

Halbrook C, Lyssiotis C, Pasca di Magliano M, Maitra A . Pancreatic cancer: Advances and challenges. Cell. 2023; 186(8):1729-1754. PMC: 10182830. DOI: 10.1016/j.cell.2023.02.014. View

Sun Y, Chen H, Lai X . ELAVL1-dependent SOAT2 exacerbated the pancreatitis-like cellular injury of AR42J cells induced by hyperstimulation with caerulein. Kaohsiung J Med Sci. 2024; 41(1):e12911. PMC: 11724160. DOI: 10.1002/kjm2.12911. View

Li J, Jia Y, Cao F, Wang G, Li F . An in-Depth Exploration of the Genetic Interaction Network Between Ferroptosis and Acute Pancreatitis. J Inflamm Res. 2023; 16:4425-4439. PMC: 10563811. DOI: 10.2147/JIR.S431601. View

Debnath J, Gammoh N, Ryan K . Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023; 24(8):560-575. PMC: 9980873. DOI: 10.1038/s41580-023-00585-z. View

Zhen D, Rabe K, Gallinger S, Syngal S, Schwartz A, Goggins M . BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2014; 17(7):569-77. PMC: 4439391. DOI: 10.1038/gim.2014.153. View

Carew N, Schmidt H, Yuan S, Galley J, Hall R, Altmann H . Loss of cardiomyocyte CYB5R3 impairs redox equilibrium and causes sudden cardiac death. J Clin Invest. 2022; 132(18). PMC: 9479700. DOI: 10.1172/JCI147120. View

Feng L, Chen L, Wang W, Wei Q, Chen M, Jiang X . PRMT6-mediated ADMA promotes p62 phase separation to form a negative feedback loop in ferroptosis. Theranostics. 2024; 14(10):4090-4106. PMC: 11234273. DOI: 10.7150/thno.94789. View

Yang G, Guan W, Cao Z, Guo W, Xiong G, Zhao F . Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. Clin Cancer Res. 2021; 27(12):3383-3396. DOI: 10.1158/1078-0432.CCR-19-3975. View

Cao R, Feng Z, Mo J, Wu J, Li J, Li W . Pharmacological inhibition of SREBP1 suppresses pancreatic cancer growth via inducing GPX4-mediated ferroptosis. Cell Signal. 2024; 124:111381. DOI: 10.1016/j.cellsig.2024.111381. View

10.

Douglas G, Hale A, Crabtree M, Ryan B, Hansler A, Watschinger K . A requirement for Gch1 and tetrahydrobiopterin in embryonic development. Dev Biol. 2015; 399(1):129-138. PMC: 4347993. DOI: 10.1016/j.ydbio.2014.12.025. View

11.

Dhasmana A, Dhasmana S, Kotnala S, Laskar P, Khan S, Haque S . CEACAM7 expression contributes to early events of pancreatic cancer. J Adv Res. 2023; 55:61-72. PMC: 10770095. DOI: 10.1016/j.jare.2023.02.013. View

12.

Yang J, Waldron R, Su H, Moro A, Chang H, Eibl G . Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2016; 311(4):G675-G687. PMC: 5142202. DOI: 10.1152/ajpgi.00251.2016. View

13.

Giorgio M, Trinei M, Migliaccio E, Pelicci P . Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?. Nat Rev Mol Cell Biol. 2007; 8(9):722-8. DOI: 10.1038/nrm2240. View

14.

Liu Y, Wang Y, Liu J, Kang R, Tang D . Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death. Cancer Gene Ther. 2020; 28(1-2):55-63. DOI: 10.1038/s41417-020-0182-y. View

15.

Liu Y, Lu S, Wu L, Yang L, Yang L, Wang J . The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 2023; 14(8):519. PMC: 10425449. DOI: 10.1038/s41419-023-06045-y. View

16.

Zhang W, Sun Y, Bai L, Zhi L, Yang Y, Zhao Q . RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. J Clin Invest. 2021; 131(22). PMC: 8592553. DOI: 10.1172/JCI152067. View

17.

Deng Y, Jiang T, Li J, Yu P, Mei Y, Li M . Serum iron fluctuations link ferroptosis process with mortality and prognosis of acute pancreatitis. iScience. 2023; 26(10):107774. PMC: 10505981. DOI: 10.1016/j.isci.2023.107774. View

18.

Li J, Liu J, Zhou Z, Wu R, Chen X, Yu C . Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023; 15(720):eadg3049. DOI: 10.1126/scitranslmed.adg3049. View

19.

Zhou Q, Meng Y, Le J, Sun Y, Dian Y, Yao L . Ferroptosis: mechanisms and therapeutic targets. MedComm (2020). 2024; 5(12):e70010. PMC: 11577302. DOI: 10.1002/mco2.70010. View

20.

Veglia Tranchese R, Battista S, Cerchia L, Fedele M . Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities. Biomolecules. 2024; 14(11). PMC: 11592303. DOI: 10.3390/biom14111443. View